The global Plecanatide API market was valued at US$ 142.8 Million in 2024 and is projected to reach US$ 210.5 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period (2024–2030). This robust growth is primarily driven by the increasing global prevalence of Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C), along with the expanding adoption of Plecanatide-based formulations in both developed and emerging pharmaceutical markets.

As the pharmaceutical industry focuses on developing targeted gastrointestinal therapies, the companies producing the high-purity Active Pharmaceutical Ingredient (API) for Plecanatide are critical to the supply chain. These manufacturers ensure the quality, scalability, and regulatory compliance required for global drug production. In this blog, we profile the Top 10 Companies in the Plecanatide API Industry—a mix of established pharmaceutical giants and specialized peptide synthesis experts shaping the future of GI treatment.

Download FREE Sample Report:
Plecanatide API Market – View in Detailed Research Report

---

🔟 1. Suzhou Tianma Pharma Group

Headquarters: Suzhou, Jiangsu, China
Key Offering: Plecanatide API (Purity 98%, 99%)

Suzhou Tianma Pharma Group is a leading Chinese manufacturer of pharmaceutical intermediates and APIs, with a strong focus on peptide-based therapeutics. The company has established advanced synthesis capabilities for complex molecules like Plecanatide, serving both domestic and international pharmaceutical clients.

Manufacturing Capabilities:

• State-of-the-art peptide synthesis facilities

• Strict adherence to cGMP (current Good Manufacturing Practices) standards

• Strong R&D focus on process optimization and cost-effective production

---

9️⃣ 2. Viruj Pharmaceuticals Pvt. Ltd

Headquarters: Chennai, Tamil Nadu, India
Key Offering: High-Purity Plecanatide API

Viruj Pharmaceuticals is an emerging player in the API manufacturing space, specializing in niche and complex molecules. The company has invested in developing a robust and scalable process for Plecanatide API, positioning itself as a reliable supplier for generic drug manufacturers.

Manufacturing Capabilities:

• Focus on regulatory filings in key markets (USFDA, EMA)

• Competitive pricing strategy for cost-sensitive markets

---

8️⃣ 3. ALP Pharm

Headquarters: Beijing, China
Key Offering: Plecanatide API for Clinical and Commercial Supply

ALP Pharm is a specialized contract development and manufacturing organization (CDMO) with expertise in peptide APIs. The company offers end-to-end services from process development to commercial-scale manufacturing of Plecanatide, catering to biotech and pharmaceutical companies worldwide.

Manufacturing Capabilities:

• Custom synthesis and process development services

• Capabilities for producing Peptide APIs under strict quality control

---

7️⃣ 4. Piramal Pharma Solutions

Headquarters: Mumbai, Maharashtra, India
Key Offering: Plecanatide API and Drug Product Services

Piramal Pharma Solutions is a globally recognized CDMO offering integrated services across the drug development lifecycle. Their extensive experience in complex API manufacturing, including peptides, makes them a significant contender in the Plecanatide supply chain.

Manufacturing Capabilities:

• Global manufacturing network with regulatory approvals

• Integrated services from API to finished dosage form

Download FREE Sample Report:
Plecanatide API Market – View in Detailed Research Report

---

6️⃣ 5. Rochem International Inc

Headquarters: Los Angeles, California, USA
Key Offering: Plecanatide API Sourcing and Distribution

Rochem International operates as a global supplier and distributor of pharmaceutical APIs and intermediates. The company facilitates access to Plecanatide API for pharmaceutical companies, leveraging its robust supply chain and quality assurance protocols.

Manufacturing Capabilities:

• Global logistics and supply chain management

• Quality verification and regulatory compliance support

---

5️⃣ 6. Anthem Biosciences

Headquarters: Bangalore, Karnataka, India
Key Offering: Plecanatide API Contract Manufacturing

Anthem Biosciences is a research-driven biopharmaceutical company offering contract research and manufacturing services. Their strong capabilities in fermentation and synthetic biology extend to complex peptide APIs like Plecanatide.

Manufacturing Capabilities:

• Advanced R&D facilities for process innovation

• Focus on sustainable and efficient manufacturing processes

---

4️⃣ 7. Auro Peptides Limited

Headquarters: Hyderabad, Telangana, India
Key Offering: High-Purity Peptide APIs including Plecanatide

Auro Peptides, a part of the Aurobindo Pharma network, specializes exclusively in the development and manufacture of peptide APIs. The company leverages its parent group’s extensive infrastructure to produce Plecanatide at scale for global markets.

Manufacturing Capabilities:

• Dedicated peptide synthesis plants

• Strong regulatory dossier preparation and submission expertise

---

3️⃣ 8. Aurobindo Pharma Limited

Headquarters: Hyderabad, Telangana, India
Key Offering: Plecanatide API and Finished Dosage Forms

Aurobindo Pharma is a major Indian multinational pharmaceutical manufacturer with a vast portfolio of APIs and formulations. The company’s vertical integration strategy includes the production of Plecanatide API for its own generic drug development and for supply to other manufacturers.

Manufacturing Capabilities:

• Large-scale manufacturing capacity

• Extensive global regulatory footprint

---

2️⃣ 9. MSN Laboratories

Headquarters: Hyderabad, Telangana, India
Key Offering: Plecanatide API for Generic Drug Applications

MSN Laboratories is a research-focused pharmaceutical company with significant investments in API development. The company is actively involved in creating non-infringing processes for Plecanatide API to support the future generic market upon patent expiry.

Manufacturing Capabilities:

• Strong intellectual property and patent analysis team

• Robust chemistry, manufacturing, and controls (CMC) development

---

1️⃣ 10. Mylan Inc (now part of Viatris)

Headquarters: Canonsburg, Pennsylvania, USA
Key Offering: Plecanatide API and Generic Formulations

Viatris, formed from the merger of Mylan and Upjohn, is a global pharmaceutical company. With Mylan’s legacy strength in generics and complex APIs, the company is positioned as a key future supplier of Plecanatide API, particularly for the anticipated generic market.

Manufacturing Capabilities:

• Global regulatory expertise for ANDA (Abbreviated New Drug Application) submissions

• Extensive distribution network for finished generic products

Get Full Report Here:
Plecanatide API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Plecanatide API Is Driven by Generic Expansion and Innovation

The Plecanatide API market is on the cusp of significant transformation. While the branded drug Trulance® (plecanatide) continues its market presence, the impending patent expiries are catalyzing preparation for a competitive generic landscape. API manufacturers are investing in developing efficient, cost-effective, and non-infringing synthetic routes to capture future demand.

📈 Key Trends Shaping the Market:

• Accelerated R&D for generic Plecanatide API processes ahead of patent cliffs

• Growing demand for high-purity (≥99%) API from formulation manufacturers

• Increasing outsourcing of peptide API manufacturing to specialized CDMOs in Asia

• Strategic partnerships between API suppliers and generic pharmaceutical companies

Get Full Report Here:
Plecanatide API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical gastrointestinal drug ingredient—they are enabling broader patient access to effective treatments through innovation and scale.